InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,335.37
(
0.14%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: bladerunner1717 post# 151317

Friday, 10/26/2012 7:03:37 PM

Friday, October 26, 2012 7:03:37 PM

Post# of 252302
Yes, KOL's like Dr Cortez are beginning to make the case that using ponatinib in a front-line setting may prevent mutations from developing in the first place. He mentions this possibility in an interview he gave at ASCO (starts around the 9:30 mark) https://accesscmldrugs.wordpress.com/2012/10/14/dr-jorge-cortes-explains-latest-on-existing-and-emerging-treatments/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up